Impact on rates and time to first central vascular-associated bloodstream infection when switching from open to closed intravenous infusion containers in a hospital setting

Epidemiology and Infection

Volumn 137, Issue 7, 2009, Pages 1041-1048

  Franzetti, F ^a   Borghi, B ^a   Raimondi, F ^a   Rosenthal, Victor D ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Medical College of Buenos Aires   (Argentina)

Author keywords

Bloodstream infection; Central venous catheter; Closed and open infusion containers; Healthcare associated infection; Intensive care unit

Indexed keywords

ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; CONTAINER; FEMALE; GAUZE DRESSING; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; INTRAVENOUS INFUSION CONTAINER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPEN STUDY; BACTEREMIA; CENTRAL VENOUS CATHETERIZATION; DRUG PACKAGING; HOSPITAL; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED;

AGED; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; DRUG PACKAGING; FEMALE; HOSPITALS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED;

EID: 67650445841     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880800174X     Document Type: Article

References (39)

1. Crnich CJ, Maki DG. The role of intravascular devices in sepsis. Current Infectious Diseases Report 2001; 3: 496-506.
2. Rosenthal VD, et al. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. American Journal of Infection Control 2003; 31: 475-480.
3. Haley RW, et al. Update from the SENIC project. Hospital infection control : Recent progress and opportunities under prospective payment. American Journal of Infection Control 1985; 13: 97-108.
4. Gastmeier P, et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. Journal of Hospital Infection 2006; 64: 16-22.
5. O'Grady NP, et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics 2002; 110: E51.
6. Macias AE, et al. Parenteral infusions bacterial contamination in a multi-institutional survey in Mexico: Considerations for nosocomial mortality. American Journal of Infection Control 1999; 27: 285-290.
7. Maki DG, Anderson RL, Shulman JA. In-use contamination of intravenous infusion fluid. Applied Microbiology 1974; 28: 778-784.
8. Rosenthal VD, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Annals of Internal Medicine 2006; 145: 582-591.
9. Rosenthal VD, Maki DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia. American Journal of Infection Control 2004; 32: 135-141.
10. Epstein SE. Cost-effective application of the Centers for Disease Control guideline for prevention of catheter-associated urinary tract infections. American Journal of Infection Control 1985; 13: 272-275.
11. Tablan OC, et al. Guidelines for preventing health-care-associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. Morbidity and Mortality Weekly Report 2004; 53: 1-36.
12. Mangram AJ, et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. American Journal of Infection Control 1999; 27: 97-132.
13. Maki DG, et al. Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features. American Journal of Medicine 1976; 60: 471-485.
14. Goldmann DA, et al. The role of nationwide nosocomial infection surveillance in detecting epidemic bacteremia due to contaminated intravenous fluids. American Journal of Epidemiology 1978; 108: 207-213.
15. Munoz JM, et al. Control of pediatric nosocomial bacteremia by a program based on culturing of parenteral solutions in use. Salud Publica de México 1999; 41 (Suppl. 1): S32-37.
16. Centers for Disease Control and Prevention (CDC). Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications - Brazil, 1996. Morbidity and Mortality Weekly Report 1998, 47: 610-612.
17. Matsaniotis NS, et al. Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infection Control 1984; 5: 471-477.
18. Kilian J, et al. Bacterial contamination as a complication of intravenous therapy in intensive care [in German]. Der Anaesthesist 1980; 29: 559-566.
19. McAllister JC, Buchanan EC, Skolaut MW. A comparison of the safety and efficiency of three intermittent intravenous therapy systems - the minibottle, the minibag and the inline burette. American Journal of Hospital Pharmacy 1974; 31: 961-967.
20. Emori TG, et al. National Nosocomial Infections Surveillance System (NNIS): Description of surveillance methods. American Journal of Infection Control 1991; 19: 19-35.
21. Garner JS, et al. CDC definitions for nosocomial infections, 1988. American Journal of Infection Control 1988; 16: 128-140.
22. Rosenthal VD, et al. Effect of education and performance feedback on handwashing: The benefit of administrative support in Argentinean hospitals. American Journal of Infection Control 2003; 31: 85-92.
23. Rosenthal VD, et al. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. American Journal of Infection Control 2003; 31: 405-409.
24. Higuera F, et al. The effect of process control on the incidence of central venous catheter-associated blood-stream infections and mortality in intensive care units in Mexico. Critical Care Medicine 2005; 33: 2022-2027.
25. Ramirez Barba EJ, et al. Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. American Journal of Infection Control 2006; 34: 244-247.
26. Moreno CA, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals : Findings of the International Nosocomial Infection Control Consortium. Infection Control and Hospital Epidemiology 2006; 27: 349-356.
27. Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infection Control and Hospital Epidemiology 2004; 25: 251-255.
28. Lynch P, et al. Infection control : A global view. In: Jarvis WR, ed. Bennett and Brachman's Hospital Infections, 5th edn. San Francisco, CA: Lippincott, Williams, and Wilkins, 2008, pp. 255-271.
29. Rosenthal VD, et al. International Nosocomial Infection Control Consortium (INICC) Report, Data Summary for 2002-2007, Issued January 2008. American Journal of Infection Control (in press).
30. Salomão R, et al. Device-associated infections rates in critical patients of Brazilian hospitals. International Nosocomial Infection Control Consortium (INICC) Findings. Pan American Journal of Public Health (in press).
31. Cuellar L, et al. Device-associated infections rates and mortality in intensive care units of Peruvian hospitals. International Nosocomial Infection Control Consortium (INICC) Findings. Pan American Journal of Public Health (in press).
32. Mehta A, et al. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). Journal of Hospital Infection 2007; 67: 168-174.
33. Leblebicioglu H, et al. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). Journal of Hospital Infection 2007; 65: 251-257.
34. Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. American Journal of Infection Control 2005; 33: 501-509.
35. Higuera F, et al. The attributable cost, and length of hospital stay of central line associated blood stream infection in intensive care units in Mexico. A prospective, matched analysis. In: Proceedings and Abstracts of the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. Los Angeles, CA, USA, 2005, p. 104.
36. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Archives of Internal Medicine 1995; 155: 1177-1184.
37. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. Journal of the American Medical Association 1994; 271: 1598-1601.
38. Jarvis WR. The evolving world of healthcare-associated bloodstream infection surveillance and prevention : Is your system as good as you think? Infection Control and Hospital Epidemiology 2002; 23: 236-238.
39. Raad II, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology 1994; 15: 231-238.